top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
55111-0153-13 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (1X3,FILM-COATED) 4 MG | PO |
55111-0153-30 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | PO |
55111-0154-13 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (1X3,FILM-COATED) 8 MG | PO |
55111-0154-30 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | PO |
55111-0156-11 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (1X1,FILM-COATED) 24 MG | PO |
55111-0496-60 | None | CAPECITABINE, 150 MG, ORAL | CAPECITABINE (USP,FILM COATED) 150 MG | PO |
55111-0497-04 | None | CAPECITABINE, 500 MG, ORAL | CAPECITABINE (USP,FILM COATED) 500 MG | PO |
55111-0525-01 | J7507 | TACROLIMUS, IMMEDIATE RELEASE, ORAL, 1 MG | TACROLIMUS (HARD GELATIN) 0.5 MG | PO |
55111-0526-01 | J7507 | TACROLIMUS, IMMEDIATE RELEASE, ORAL, 1 MG | TACROLIMUS (HARD GELATIN) 1 MG | PO |
55111-0527-01 | J7507 | TACROLIMUS, IMMEDIATE RELEASE, ORAL, 1 MG | TACROLIMUS (HARD GELATIN) 5 MG | PO |
55111-0652-07 | J0583 | INJECTION, BIVALIRUDIN, 1 MG | BIVALIRUDIN (SINGLE-USE,LYOPHILIZED) 250 MG | IV |
55111-0652-37 | J0583 | INJECTION, BIVALIRUDIN, 1 MG | BIVALIRUDIN (SINGLE-USE,LYOPHILIZED) 250 MG | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page